National Stroke Foundation


The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved December 1997

Specific Treatments:


General Information

Etodolac has been approved in 200mg and 300mg strengths. It is currently available in 400mg, and is the generic equivalent of Wyeth-Ayerst's Lodine.